Breaking AI & Tech News Analyzed

The Explicit RoleNot many actors are relieved when they have to film an eye-poppingly explicit sex scene, but that was the case with Jamie Bell on Half Man. His role involved chemsex in saunas, dogging in car parks and illicit quickies in library loos. "Honestly, I was so grateful to be shooting that stuff and not fucking 16-page dialogue scenes, where you're emoting and it's so intense," says Bell. "On days when my character had to have sex with random people, I'd think: 'Thank God!' Frankly, it came as a welcome reprieve."The Creative PartnershipRichard Gadd's first TV show since the Emmy-gobbling global Netflix hit Baby Reindeer, Half Man chronicles the combustible, codependent relationship between two "brothers from another lover". Niall (Bell) is bookish, bullied and closeted. Ruben (Gadd) is the swaggeringly violent ex-con son of his mother's girlfriend. The six-part drama – which reaches its devastating finale next week – traces the inseparable duo's toxic relationship across three decades.The role of Niall was written specifically for Bell. "I didn't realise that when I initially read the scripts," says Bell. "But later, when I met Richard in Los Angeles to discuss it, he said he wrote it with me in mind. I was incredibly flattered … It's a sensory experience reading Richard's material. He truly takes you to those places in your own life. It probes experiences you've kept hidden away somewhere and chosen to forget."Character ComplexityHe was drawn to his Half Man character's complexity. "I thought: 'Woah, this man is on such a destructive downward spiral …' He's got everything he wanted in life but still can't accept who he is. Niall is living as several different people and he's not comfortable with any of them."Bell really empathised with gentle Niall being drawn to such an aggressive alpha male. "Ruben is this disaster of a man. A bull in a china shop, destroying everything and everyone in his wake. Why doesn't Niall step away? Partly self-preservation. Niall feels vulnerable whereas Ruben is intimidatingly powerful. He can be Niall's protector. People fear him. Because of that, Niall latches on to him almost parasitically. Ruben becomes his life support system. I understood that 100%."I grew up in an all-female household and did ballet, so I used to attach myself to tough, troubled guys too. Not my kind of crowd at all but I'd rather have them on my team than not."Themes of Toxic MasculinityNiall struggles with his sexuality to the extent that he undergoes conversion therapy. As a straight man, Bell felt an acute sense of responsibility portraying that. "It's the centre of the character," he says. "The basis of all his issues. I took that very seriously. Niall's self-hate goes beyond shame or societal pressure. Somehow, his own sexuality doesn't sit right within his worldview. That, to me, is beyond sad. 'Be yourself' is the simplest advice yet at times, the hardest to adhere to." As a result of his turmoil, Niall goes to some dark places sexually. "Because of his repression, everything is guarded and hidden. That becomes the excitement. It's an addiction. He gets a kick from dangerous sex."With its portrayal of male rage and damaged antiheroes, Half Man taps into debates about toxic masculinity. Does Bell believe his gender is in crisis? "Look at who are the majority transgressors in this world," he says. "It's men, on all fronts – not just misogyny but conflict, crime, everything. It's important to shine a light on that. The conversation is ongoing. Hopefully this show adds something."The ImpactIt's no-holds-barred TV, full of sex, violence and gut-punch plot twists. "It's a brutal, beastly thing that Richard has created," says Bell. "I'd be lying if I said it was easy or fun to make." Yet the show represents a significant moment in television, pushing boundaries in its depiction of complex male relationships and sexuality. Bell's performance as Niall, combined with Gadd's writing and performance as Ruben, creates a character study that resonates with contemporary discussions about identity, self-acceptance, and the destructive patterns that can emerge from unresolved trauma.

The Rise of African ContendersSenegal coach Pape Thiaw has set an ambitious target for his team at the upcoming World Cup in North America, declaring that if he doubted they could win the tournament, he would step aside. This bold statement reflects both the confidence Senegal has earned in international football and the changing landscape of African teams on the world stage."Those were not just empty words. The players and the coach believe they can win the World Cup," Babacar Diarra, a French-Senegalese freelance journalist, told Al Jazeera. "Although the first match [against France] will tell us a lot about how good this team truly is."The Academy ParadoxFor a country of just 20 million people, Senegal produces talented young footballers at a scale unparalleled on the continent. Several state-of-the-art academies have opened in Senegal, equipped with pristine training pitches, dormitories, schools and physical therapy facilities. Each year, they send several players into the top European leagues.Of the 28 players Senegal selected for the 2025 Africa Cup of Nations, 13 came from Senegalese academies such as Generation Foot, Diambars, Dakar Sacre Coeur or Casa Sports. Yet this success comes with a striking paradox: while these academies produce world-class players, they generate minimal financial returns compared to the massive transfer fees these players command in Europe.The Economics of Talent DevelopmentThe financial disparities in Senegalese football are staggering. The 13 AFCON players from academy backgrounds generated just 100,000 euros ($116,000) in transfer fees across 13 moves for their respective academies. The European clubs that initially acquired them sold them on to convert those investments into a combined 81.2 million euros ($94m). Across their careers, those same players have generated a total of 411 million euros ($477m) in transfer fees."On one hand, youngsters benefit from good education and access to top infrastructure," explains Mamadou Ndiaye, a loyal supporter of the national team. "Yet we should not forget that the investors funding the academies are businessmen – it is not the federation or the government. They know there's talent here, they put their money in, capture the 'raw material', refine it and sell it to Europe."Strategic Diaspora RecruitmentIn addition to producing talent through its academies, Senegal has developed a sophisticated approach to recruiting from the Western European diaspora. The federation has persuaded French-born 18-year-old Paris Saint-Germain (PSG) forward Ibrahim Mbaye and 20-year-old Chelsea defender Mamadou Sarr to represent the Teranga Lions, despite both having featured for France at the U20 level."The federation's policy rests on three distinct pillars," explains Cherif Sadio, director of development, strategy and partnerships at Diambars FC. "Firstly, they target diaspora players between the ages of 16 and 19, before they become tied to another country. The second point has to do with identity. Although they're born in countries like France or England, these players often grow up in Senegalese households where culture, language and values are passed down, and the federation uses that to its advantage."The Future of Senegalese FootballFor this golden generation of players – Sadio Mane, Kalidou Koulibaly, Idrissa Gana Gueye and Edouard Mendy – the 2026 World Cup represents the opportune moment. It's now or never to translate their consistent continental success into World Cup glory.Yet the challenges remain significant. As Sadio notes, "It is the most striking paradox of Senegalese football, and it deserves to be stated clearly. We produce world-class players, we develop talents who generate hundreds of millions of euros in transfer fees, we win continental titles – and at the same time our local clubs struggle to survive, our stadiums are dilapidated, our leagues lack visibility, and our administrators struggle to master the legal and financial mechanisms of modern football."

Alan Davies' Candid Conversation at the Pleasance TheatreDuring a relaxed sit‑down at the Pleasance fringe venue in Islington, Alan Davies opened up about his latest memoir, his childhood abuse, the role of ego in comedy, his battles with alcohol and a recent cancer diagnosis. The interview offers a rare glimpse into the personal challenges behind the public persona of the beloved British comedian.Revealing Childhood Abuse and Its Aftermath in "Just Ignore Him" and "White Male Stand‑Up"2020: Publication of the first autobiography Just Ignore Him, where Davies disclosed sexual abuse by his father and the discovery of his father’s pornographic collection.2025: Release of the follow‑up memoir White Male Stand‑Up, focusing on the 1990s comedy circuit, fame, and the darker side of the industry.Davies describes therapy sessions, the lingering impact of trauma on his behaviour, and the catharsis of finally confronting his past.Sales, Media Reach and Public Reaction to Davies' Recent MemoirsBoth books have generated extensive media coverage, including multiple interviews on radio, TV and print.Social‑media engagement spiked after the release of White Male Stand‑Up, with readers sharing personal stories of abuse and gratitude for Davies' openness.While exact sales figures are not disclosed, the memoirs have been highlighted in bestseller lists for memoirs and comedy literature in the UK.How the Revelations Reshape Perceptions of Comedy Culture and CelebrityDavies' admission that fame can fuel ego and destructive habits—ranging from heavy drinking to occasional violent outbursts—adds nuance to the public’s understanding of the comedy world. By linking his personal trauma to broader patterns of addiction and relationship breakdown, he underscores the systemic pressures faced by performers and the need for mental‑health support within the industry.Looking Forward: Davies' Next Steps and the Wider Conversation on AbuseAt 60, Davies says he is “less famous and OK with that,” yet he hopes his story will continue to encourage survivors to speak out. The interview suggests he may pursue further writing, possibly expanding on therapy dialogues, and could become an advocate for survivor‑focused initiatives in the UK entertainment sector.

The Lead: Champion's Conflicting IdentityBorn in Bedfordshire in 1980, cyclist Victoria Pendleton is one of Britain's most decorated athletes. As well as winning nine world championship golds, she won the gold medal in the sprint at the 2008 Olympics and the gold medal in the keirin, as well as a silver medal in the sprint in the 2012 Olympics. Pendleton's journey reveals a profound conflict between the traits that make an Olympic champion and those that make a popular teenager.The Athletic Journey: From Grass Track to Olympic GloryVictoria Pendleton's cycling began as a family hobby during holidays in the south of France. Her father, an avid cyclist, introduced her and her twin brother Alex to cycling on a tandem before they progressed to grass track racing at age nine. This early exposure to competitive cycling set the foundation for her future career.At 16, Pendleton's life changed when she received a call from the British Cycling Federation inviting her to try out for the team. Despite feeling like a fraud when she started professionally—sitting next to the more experienced Bradley Wiggins on a flight to her first European Championships—she would go on to win the world championship title in 2005 and Olympic gold in 2008 and 2012.The Psychological Struggle: Mental Health Behind the MedalsThroughout her career, Pendleton faced significant psychological challenges. She discovered early on that the traits that made her a successful athlete—intense competitiveness, seriousness, and a desire to win—made her an outcast among her teenage peers. This social isolation manifested as obsessive-compulsive disorder, with obsessive behaviors around food intake and excessive hand-washing.Even as her career progressed, Pendleton struggled with external perceptions. She was told she was 'too small, too puny, too feminine' by critics, while coaches mistook her smile and lightheartedness for a lack of seriousness. The pressure intensified as she approached the 2012 Olympics on home soil, where she felt the weight of expectation as a reigning world and Olympic champion.The Impact Analysis: Breaking Gender Barriers in CyclingPendleton's career coincided with a golden era for British cycling, helping to elevate the sport's profile and inspire a new generation of athletes. Her success challenged traditional gender norms in cycling, a sport where she had to navigate segregated school playgrounds and prove her capabilities in a male-dominated environment.Despite facing discrimination and underestimation of her abilities, Pendleton persevered with the support of role models like Jason Quealy, Chris Hoy, and Craig McLean. Her achievements helped pave the way for greater recognition of female athletes in cycling and other sports, demonstrating that gender should not be a barrier to excellence.The Transition: Finding Identity Beyond CompetitionRetirement from competitive cycling proved challenging for Pendleton, who had tied her identity so closely to her athletic performance. The transition was marked by a sense of loss and difficulty untangling her self-worth from her achievements. During this period, she attempted to climb Everest but had to withdraw due to health issues while also going through a divorce.To cope, Pendleton turned to extreme sports, finding therapy in surfing and eventually horse racing and motorcycling. She attributes her fearlessness in these pursuits to her childhood alongside her twin brother, who gave her confidence in her physical abilities. After her brother's passing in 2023, these activities took on even greater significance as a way to honor their shared bond.The Prediction: Legacy and Future EndeavorsToday, Pendleton has successfully reinvented herself beyond her cycling identity, finding fulfillment in new challenges and passions. Her journey—from a shy, timid girl to an Olympic champion to an extreme sports enthusiast—demonstrates the capacity for growth and reinvention that extends beyond athletic careers.As Pendleton continues to explore new horizons in horse racing and other pursuits, her story serves as an inspiration for athletes transitioning out of competition and for anyone facing identity crises after significant life changes. Her willingness to embrace fear and challenge herself anew suggests that her most remarkable achievements may still lie ahead.

What is Immunotherapy? Immunotherapies are biological treatments that harness the immune system to prevent, control and fight diseases and other conditions. The most familiar are vaccines, which train the immune system to recognise targets such as invading pathogens. Other immunotherapies boost immune responses when they are too weak, or dampen them down when they are out of control. Still others draw on engineered immune cells or lab-made antibodies to disrupt disease processes. The Evolution of Immunotherapy Efforts to prevent disease by boosting the immune system date back thousands of years, but advanced therapies for a wide range of illnesses have come to the fore in the past two decades. A global registry of clinical trials listed 1,257 trials of immunotherapies between 2006 and 2016. The figure leapt to 4,591 in the past decade. How Do Cancer Immunotherapies Work? Cancer patients have seen great benefits from immunotherapies and dozens are now approved for more than 30 types of cancer. Some tumours evade the body’s defences by switching off immune cells, but antibody-based drugs – called checkpoint inhibitors – reactivate them so they can recognise and attack the malignancies. The Future of Immunotherapy: Beyond Cancer Researchers are now testing whether existing immunotherapies can help a broader range of patients. This includes treating allergies, infections, brain diseases, and autoimmune disorders. Some of the most exciting new immunotherapies draw on recent Nobel prizewinning work on regulatory T-cells, or Tregs, which can be used to dampen down immune responses. The Potential of Tregs in Immunotherapy Tregs are unusual immune cells that stand the immune system down once the threat has been dealt with. Therapies are in the pipeline for dementia and autoimmune diseases from type 1 diabetes and rheumatoid arthritis to lupus and chronic inflammation. The potential for Tregs is vast, and researchers believe that half of all deaths have a component that is immunological.

The Lead When the founders of a mental health app for men called Mental discovered that one feature — AI interactive audio — was resonating strongly with users, they recognized a significant opportunity. This insight led to the creation of The Path, a new AI therapy application co-founded by renowned motivational speaker Tony Robbins and former Calm employees, which has now secured $14.3 million in seed funding. The Birth of a Safer AI Therapy Platform The Path emerged from observations made by co-founder and CEO Anson Whitmer and co-founder Tyler Sheaffer, who previously worked together at meditation app Calm. Whitmer's personal experiences with suicide in his family inspired him to pursue mental health technology. After working at Calm until 2021, he felt he could make a greater impact by addressing the unique, personal nature of people's mental health challenges. Whitmer sees large language models (LLMs) and AI as the bridge to providing personalized mental health care to everyone, especially given the shortage of therapists worldwide. "What's exciting and game-changing is that, for the first time in my career, I've seen that there's actually this possibility for every single person to have the personalized sort of access and care that they need to really get the help," he said. Funding and Celebrity Endorsement The Path has successfully raised $14.3 million in seed funding, led by Prime Movers Lab where Tony Robbins is a partner. Other notable investors include Olympic speed skater Apolo Anton Ohno, boxer Deontay Wilder, and Designer Fund. After Prime Movers invested, Robbins initially consulted on branding but his enthusiasm grew, leading to him becoming a co-founder. The author has since helped shape The Path into a therapy-plus-coaching app that incorporates his popular self-improvement methods. The app currently offers 11 virtual AI therapists that users can customize based on their preferences for directness and other details. While it's currently free to gain users, The Path plans to eventually charge $40 per month for the service. Superior Safety Benchmarks A key differentiator for The Path is its specially trained AI model, which has scored a 95 on the Vera-MH mental health safety AI benchmark. This significantly outperforms consumer chatbots, which top out at 65 on the same benchmark. According to Whitmer, consumer chatbots are "optimized for engagement," which is counterproductive to effective therapy and coaching that should focus on deep understanding rather than quick solutions. "It's meant to challenge you. It's not just meant to agree with you," Whitmer explains. The Path's AI is designed to help users dig out their assumptions and discover their own solutions rather than simply reinforcing ideas to keep users engaged. The startup's model is post-trained from open source models and doesn't use major consumer LLMs, positioning it as a specialized therapeutic tool rather than a generic chatbot wrapper. Market Potential and Future Outlook The mental health tech market is experiencing significant growth, with OpenAI reporting that at least 900 people use ChatGPT for mental health-related queries every week. This demonstrates the clear demand for AI-powered mental health solutions. However, The Path aims to capture a specific segment of this market by focusing on therapeutic rigor and safety. As mental health awareness continues to grow and technology becomes more sophisticated, AI therapy platforms like The Path could play an increasingly important role in addressing global mental health challenges. The combination of Tony Robbins' brand recognition, the technical expertise of the Calm alumni team, and the specialized focus on therapeutic safety positions The Path as a notable contender in the emerging field of AI-powered mental health care.

Early‑stage evidence from a University of Bristol randomised controlled trial suggests that the anti‑inflammatory drug tocilizumab may improve symptoms in patients with moderate‑to‑severe depression who have not responded to standard antidepressants.Trial Overview: Testing Tocilizumab for Treatment‑Resistant DepressionThe study examined whether blocking the IL‑6R receptor could alleviate depressive symptoms. Key design elements:Participants: 30 adults with moderate‑to‑severe depression unresponsive to conventional medication.Intervention: Intravenous tocilizumab versus placebo.Duration: four‑week double‑blind period.Outcomes measured: depression severity, fatigue, state anxiety, and quality of life.Key Numbers: Sample Size, Remission Rates, and NNTAlthough the trial was not powered to reach statistical significance, observed trends were notable:Depression remission: 54% in the tocilizumab group vs 31% in the placebo group.Number Needed to Treat (NNT): 5, meaning five patients would need treatment for one additional remission.For comparison, the NNT for first‑line SSRIs is approximately 7.The lack of robust statistical proof reflects the small cohort, underscoring the need for larger studies.Potential Shift in Depression Treatment ParadigmsResearchers describe the trial as an “important milestone” because it is:One of the first randomised trials to test immunotherapy for depression.The inaugural study targeting the IL‑6R pathway in this context.A proof‑of‑concept for selecting patients based on biological markers.Given that up to one‑third of depressed patients do not improve with existing pharmacotherapies, a biologically driven approach could expand therapeutic options and move psychiatry toward more personalised care.What Comes Next: Larger Studies and Clinical ImplicationsThe investigators plan to:Conduct larger, multi‑centre trials to confirm efficacy and safety.Explore longer treatment durations and dosage optimisation.Assess whether IL‑6R blockade can be combined with existing antidepressants.If subsequent trials replicate these findings, immunotherapy could become a viable adjunct or alternative for treatment‑resistant depression, potentially reshaping clinical guidelines and drug development pipelines.

From Anna Forbes to Glasgow Therapist: A Personal JourneyThe Guardian revisits Daniela Nardini nearly three decades after her breakout role as Anna Forbes in This Life. Once a cultural touchstone of late‑90s Britain, she now runs a therapy practice in the West End of Glasgow, offering a quiet contrast to the sharp, messy character that once defined her.Viewership Numbers and Awards Highlight Nardini’s Early Impact3.5 million viewers tuned in to This Life at its peak, making the series a BBC Two hit.1998: Nardini earned a BAFTA for her performance.2009: She won a Scottish BAFTA for the film New Town.These figures cemented her status as a role model for a generation of young women navigating the “work‑hard, play‑hard” ethos of the era.How Mid‑life Transitions Reshape Identity in the Public EyeAfter the series ended, Nardini faced a series of personal upheavals: the death of her father Aldo, the dissolution of her marriage to restaurateur Ivan Stein, and a breast‑cancer diagnosis that required a mastectomy and reconstruction. The experience prompted her to retrain as a therapist seven years ago, a shift she describes as more than a simple “pivot.”Her clients, predominantly women in midlife, benefit from her lived experience of grief, loss and bodily change, giving her practice a uniquely empathetic edge.What Lies Ahead for Nardini’s Dual Career PathLooking forward, Nardini plans to continue blending her artistic sensibility with therapeutic work, using creative outlets such as painting to process trauma. While she does not anticipate a resurgence of Anna Forbes‑related clientele, she remains open to occasional acting projects that align with her new perspective.As she approaches her 60th birthday, Nardini embodies a narrative of resilience: “quite a lot happened in my 50s,” she reflects, suggesting that the next decade will be defined by the strength she has cultivated through both fame and personal adversity.

The LeadIranian human rights activist and 2023 Nobel Peace Prize laureate Narges Mohammadi has returned to her home after being discharged from Pars Hospital in Tehran. The 54-year-old activist, who has been imprisoned since December, requires ongoing medical care following a severe cardiac crisis that led to her hospitalization in early May.The Medical SituationMohammadi was transferred from prison to Pars Hospital in early May after experiencing two episodes of loss of consciousness and a severe cardiac crisis. According to her foundation, she is "scheduled to follow up on her medical complications with her medical team through hospital visits and daily outpatient physiotherapy over the coming weeks". Doctors have emphasized that it is "vital she remains under close medical observation" due to her deteriorating health condition.The Legal BackgroundMohammadi was imprisoned in December after being arrested during a visit to the eastern Iranian city of Mashhad. In February, she was sentenced to more than seven years in prison, with six years of that sentence for "collusion to commit crimes". Her family alleges that her health declined sharply due to a beating she endured during her arrest, which they claim involved multiple men kicking her all over her body. In late March, as she began her prison sentence, she suffered a heart attack.The International ResponseMohammadi's daughter and co-president of the Narges Foundation, Kiana Rahmani, stated that returning her mother to prison would be "a death sentence". She emphasized, "We must ensure she remains free, all baseless charges against her are permanently dropped, and the persecution ends. Human rights activism is not a crime, and no advocate should ever be imprisoned for it." The international community has closely monitored Mohammadi's case, particularly since her Nobel Peace Prize win in 2023.The Future OutlookAs Mohammadi continues her recovery at home, her legal situation remains uncertain. The activist, who has been arrested 13 times and convicted on five separate occasions with sentences exceeding 30 years, faces the ongoing challenge of balancing her medical needs with her legal obligations. Her case has become a focal point for human rights advocates worldwide, particularly regarding the treatment of political prisoners in Iran and the specific challenges faced by women's rights activists in the country.